{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:18:01Z","timestamp":1790543881085,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012619","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red Fragilidad y Envejecimiento Saludable","doi-asserted-by":"publisher","award":["CB16\/10\/00245"],"award-info":[{"award-number":["CB16\/10\/00245"]}],"id":[{"id":"10.13039\/100012619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012619","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red Fragilidad y Envejecimiento Saludable","doi-asserted-by":"publisher","award":["FIS PI13\/00444"],"award-info":[{"award-number":["FIS PI13\/00444"]}],"id":[{"id":"10.13039\/100012619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.bone.2017.06.018","type":"journal-article","created":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T07:46:39Z","timestamp":1498290399000},"page":"64-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Fracture during oral bisphosphonate therapy is associated with deteriorated bone material strength index"],"prefix":"10.1016","volume":"103","author":[{"given":"Xavier","family":"Nogu\u00e9s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Prieto-Alhambra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"G\u00fcerri-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6507-0147","authenticated-orcid":false,"given":"Natalia","family":"Garcia-Giralt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Rodriguez-Morera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Cos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Mellibovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo D\u00edez","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2017.06.018_bb0005","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1210\/jc.2009-1947","article-title":"Long-term use of bisphosphonates in osteoporosis","volume":"95","author":"Watts","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2017.06.018_bb0010","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","article-title":"Ten years' experience with alendronate for osteoporosis in postmenopausal women","volume":"350","author":"Bone","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2017.06.018_bb0015","first-page":"515","article-title":"Clinical practice guidelines for posmenopausal, glucocorticoid-induced and male osteoporosis. Spanish Society for Research on Bone and Mineral Metabolism (3rd updated version 2014)","volume":"215","author":"Gonzalez-Macias","year":"2015","journal-title":"Rev. Clin. Esp."},{"key":"10.1016\/j.bone.2017.06.018_bb0020","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","article-title":"Clinician's guide to prevention and treatment of osteoporosis","volume":"25","author":"Cosman","year":"2014","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2017.06.018_bb0025","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11657-013-0136-1","article-title":"Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA)","volume":"8","author":"Hernlund","year":"2013","journal-title":"Arch. Osteoporos."},{"key":"10.1016\/j.bone.2017.06.018_bb0030","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1007\/s00198-012-2093-8","article-title":"Treatment failure in osteoporosis","volume":"23","author":"Diez-Perez","year":"2012","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2017.06.018_bb0035","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/jc.2012-3680","article-title":"Treat-to-target for osteoporosis: is now the time?","volume":"98","author":"Lewiecki","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2017.06.018_bb0040","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/jbmr.1496","article-title":"Risk factors for prediction of inadequate response to antiresorptives","volume":"27","author":"Diez-Perez","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.06.018_bb0045","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/jbmr.2011","article-title":"Predictors of fracture while on treatment with oral bisphosphonates: a population-based cohort study","volume":"29","author":"Prieto-Alhambra","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.06.018_bb0050","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/jbmr.2497","article-title":"Bone tissue properties measurement by reference point indentation in glucocorticoid-induced osteoporosis","volume":"30","author":"Mellibovsky","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.06.018_bb0055","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1210\/jc.2014-4346","article-title":"Bone material strength as measured by microindentation in vivo is decreased in patients with fragility fractures independently of bone mineral density","volume":"100","author":"Malgo","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2017.06.018_bb0060","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/jbmr.2106","article-title":"In vivo assessment of bone quality in postmenopausal women with type 2 diabetes","volume":"29","author":"Farr","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.06.018_bb0065","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","article-title":"Vertebral fracture assessment using a semiquantitative technique","volume":"8","author":"Genant","year":"1993","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.06.018_bb0070","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bonr.2016.07.004","article-title":"Technical note: recommendations for a standard procedure to assess cortical bone at the tissue-level in vivo using impact microindentation","volume":"5","author":"Diez-Perez","year":"2016","journal-title":"Bone Rep."},{"key":"10.1016\/j.bone.2017.06.018_bb0075","doi-asserted-by":"crossref","DOI":"10.1063\/1.3693085","article-title":"A new device for performing reference point indentation without a reference probe","volume":"83","author":"Bridges","year":"2012","journal-title":"Rev. Sci. Instrum."},{"key":"10.1016\/j.bone.2017.06.018_bb0080","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/jbmr.2069","article-title":"Assessment of incident spine and hip fractures in women and men using finite element analysis of CT scans","volume":"29","author":"Kopperdahl","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.06.018_bb0085","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/jbmr.1472","article-title":"Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures","volume":"27","author":"Austin","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.06.018_bb0090","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/QAI.0000000000000965","article-title":"HIV infection is associated with worse bone material properties, independently of bone mineral density","volume":"72","author":"Guerri-Fernandez","year":"2016","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.bone.2017.06.018_bb0095","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1007\/s00198-014-2787-1","article-title":"Goal-directed treatment of osteoporosis in Europe","volume":"25","author":"Kanis","year":"2014","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2017.06.018_bb0100","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/jbmr.2603","article-title":"True gold or pyrite: a review of reference point indentation for assessing bone mechanical properties in vivo","volume":"30","author":"Allen","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.06.018_bb0105","article-title":"Comparison of cyclic and impact-based reference point indentation measurements in human cadaveric tibia","author":"Karim","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.06.018_bb0110","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/jbmr.2537","article-title":"Are the high hip fracture rates among Norwegian women explained by impaired bone material properties?","volume":"30","author":"Duarte Sosa","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.06.018_bb0115","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.bone.2012.12.015","article-title":"Reference-point indentation correlates with bone toughness assessed using whole-bone traditional mechanical testing","volume":"53","author":"Gallant","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.06.018_bb0120","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/jbmr.2605","article-title":"Site-dependent reference point microindentation complements clinical measures for improved fracture risk assessment at the human femoral neck","volume":"31","author":"Jenkins","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.06.018_bb0125","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s00198-015-3419-0","article-title":"Bone material strength is associated with areal BMD but not with prevalent fractures in older women","volume":"27","author":"Rudang","year":"2016","journal-title":"Osteoporos. Int."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217302168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217302168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:38:27Z","timestamp":1762659507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328217302168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":25,"alternative-id":["S8756328217302168"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2017.06.018","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fracture during oral bisphosphonate therapy is associated with deteriorated bone material strength index","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2017.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}